Michael Ho is a seasoned pharmacologist with over 20 years of experience in drug discovery. Currently, as a Director of Safety and Mechanistic Pharmacology at AstraZeneca, they utilize their extensive background in progressing small molecules for various therapeutic areas, including cancer and neurodegenerative diseases. They have held senior roles at prominent companies, such as Senior Principal Scientist at BenevolentAI and Team Leader at Upsher-Smith, showcasing a blend of technical and managerial expertise. Michael earned a Bachelor’s degree in Pharmacology from the University of Sunderland and a PhD in Neuroscience from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices